다우존스 지수

브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

등록

GNT

Gentium Spa (GNT)

Gentium Spa Ads

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:AMEX:GNT

1

일자	시간	출처	헤드라인	심볼	기업
2006/05/16	21:00	Business Wire	Gentium Begins Trading on NASDAQ; New Ticker Symbol: GENT	AMEX:GNT	Gentium Spa Ads
2006/05/05	21:42	Business Wire	Gentium to Trade on NASDAQ National Market	AMEX:GNT	Gentium Spa Ads
2006/04/13	19:00	Business Wire	Gentium Reports 2005 Financial Results; Provides Financial and Clinical Update	AMEX:GNT	Gentium Spa Ads
2006/03/28	22:00	Business Wire	Gentium Receives First IRB Approval to Begin U.S. Phase III Trial with Defibrotide to Treat Veno-Occlusive Disease with Multipl	AMEX:GNT	Gentium Spa Ads
2006/02/02	22:00	Business Wire	Gentium to Present at Angiogenesis in Cancer and Vascular Disease Congress; Defibrotide Has Anti-Angiogenic Properties In Vitro	AMEX:GNT	Gentium Spa Ads
2006/01/30	22:00	Business Wire	Gentium's Defibrotide Subject of Independent Study in Japan; First Japanese Study Reports That Defibrotide Shows Success Treatin	AMEX:GNT	Gentium Spa Ads
2006/01/20	21:30	Business Wire	Gentium Initiates Phase II/III Pediatric Trial with Defibrotide to Prevent Veno-Occlusive Disease; European Group for Blood and	AMEX:GNT	Gentium Spa Ads
2005/11/15	21:00	Business Wire	Gentium Reports Third Quarter Financial Results; Provides Financial and Clinical Update	AMEX:GNT	Gentium Spa Ads
2005/11/08	00:12	Business Wire	Gentium to Present at Rodman & Renshaw Techvest Seventh Annual Healthcare Conference	AMEX:GNT	Gentium Spa Ads
2005/10/17	19:00	Business Wire	Gentium Completes $10.9 Million Private Placement	AMEX:GNT	Gentium Spa Ads
2005/10/04	22:23	Business Wire	Gentium Raises $10.9 Million in Private Offering; Funding to Support New Trials and Continued Development of Pipeline	AMEX:GNT	Gentium Spa Ads
2005/09/21	19:00	Business Wire	Gentium S.p.A. Announces Initiation of Independent Phase I/II Study of Defibrotide to treat Multiple Myeloma	AMEX:GNT	Gentium Spa Ads
2005/09/15	17:00	Business Wire	Renowned Bone Marrow Transplantation Expert Richard E. Champlin, M.D., Joins Gentium's Scientific Advisory Board	AMEX:GNT	Gentium Spa Ads
2005/09/07	17:00	Business Wire	Gentium S.p.A. Announces Intention to Commence Phase III Trial Following Discussions with FDA	AMEX:GNT	Gentium Spa Ads
2005/08/10	17:00	Business Wire	Gentium Reports Second Quarter Financial Results, Provides Clinical Update	AMEX:GNT	Gentium Spa Ads
2005/08/09	17:00	Business Wire	Gentium Presented Laboratory Data at XXth Congress of International Society for Thrombosis and Haemostasis; Laboratory Data Pres	AMEX:GNT	Gentium Spa Ads
2005/07/14	05:05	Business Wire	Gentium S.p.A. Announces FDA Agrees Company's CMC Submission is Adequate for Commencing Phase III Clinical Trials with Defibroti	AMEX:GNT	Gentium Spa Ads
2005/06/17	07:10	PR Newswire (US)	American Stock Exchange Lists American Depository Shares Representing Ordinary Shares Of Gentium S.p.A	NYSE:GNT
2005/06/17	01:38	PR Newswire (US)	Gentium S.p.A. Announces Pricing of Initial Public Offering	NYSE:GNT

검색 관련기사 보기:AMEX:GNT

1

US Dollar vs Euro

BNP Paribas (QX)

American Express

Verizon Communications

Gold vs US Dollar

US Dollar vs Yen

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관